当前位置: 首页 > 期刊 > 《咸宁学院学报(医学版)》 > 2006年第4期
编号:11342332
可明胶囊治疗单纯型糖尿病性视网膜病变的疗效观察
http://www.100md.com 《咸宁学院学报(医学版)》 2006年第4期
可明胶囊;糖尿病性视网膜病变,,可明胶囊;糖尿病性视网膜病变,1资料与方法,2结果,3讨论,参考文献:
     摘要:目的 观察可明胶囊治疗单纯型糖尿病性视网膜病变(DR)的疗效。方法 将60例单纯型DR患者随机分为2组,每组30例。对照组患者接受常规的对症、支持治疗;实验组患者在常规治疗基础上服用可明胶囊。比较2组患者治疗开始时、治疗后1个月和2个月的视力及眼底病变情况。 结果 实验组患者治疗后1个月及2个月的视力及眼底病变的改善均优于对照组(均P<0.05);2组患者均未出现明显毒副反应和副作用。 结论 可明胶囊治疗单纯型DR的疗效显著,安全性高,是治疗该病的有效药物。

    关键词:可明胶囊;糖尿病性视网膜病变

    Treatment of Diabetic Retinopathy with Kerman Capsule

    LI Ping,XIAO Qiong,GE Jun, et al

    (Department of Ophthalmology, Shenzhen People’s Hospital, Shenzhen Guangdong 518020, China)

    ABSTRACT:Objective To observe the clinical effects of kerman capsule for the treatment of diabetic retinopathy(DR). Methods In the experimental group, 30 patients with DR were treated with kerman capsule combined with routine treatment, while 30 patients with DR were only treated with routine treatment as a control group. The visual acuity and fundi were examined and compared before and after the therapy in the two groups. Results The improvement of visual acuity and retinopathy of the experimental group was greater than that of the control group (P<0.05). No significant side effects were occurred in the two groups. Conclusion It is demonstrated that kerman capsule is a safe and effective drug for the treatment of DR. ......

您现在查看是摘要页,全文长 5958 字符